المؤلفون: Yan Jia, Qiong Yang, Yutong Ma, Miaofang Wu, Qiuxiang Ou, Zhongqiu Lin, Yunyu Wu, Jing Li

المصدر: MedComm – Oncology, Vol 3, Iss 2, Pp n/a-n/a (2024)

مصطلحات موضوعية: drug resistance, homologous recombination repair, PARP inhibitor, platinum‐chemotherapy, reversion mutation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2769-6448Test

الوصول الحر: https://doaj.org/article/9b046a2050a64e2ebcc7e22423d4e9a9Test

المؤلفون: Laetitia Collet, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin, Olivia Le Saux, Isabelle Ray-Coquard

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: high grade ovarian cancer, BRCA1/2 mutation, reversion mutation, PARP inhibitor, resistance, homologous recombination deficiency, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2024.1354427/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/4ce29ee231a040ebb2aded80b23eceb5Test

المؤلفون: Auro del Giglio, Beatriz da Costa Aguiar Alves, André Márcio Murad, Fernando Luiz Affonso Fonseca

المصدر: Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-5 (2023)

مصطلحات موضوعية: BRCA2, Reversion mutation, Therapy resistance, Medicine

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1752-1947Test

الوصول الحر: https://doaj.org/article/245731edf7c244e2a9b39f524c011904Test

المؤلفون: Ayako Koki, Hirofumi Matsumoto, Hisamitsu Zaha, Mikiko Unesoko, Norie Abe, 宇根底 幹子, 幸喜 絢子, 座波 久光, 松本 裕文, 阿部 典恵

المصدر: 遺伝性腫瘍 / Journal of Hereditary Tumors. 2022, 21(3):85

المؤلفون: Taylor Ryan McFarland, Clara Elizabeth Tandar, Neeraj Agarwal, Umang Swami

المصدر: Cancer Treatment and Research Communications, Vol 29, Iss , Pp 100480- (2021)

مصطلحات موضوعية: BRCA2, Reversion mutation, PARP inhibitor, Liquid biopsy, Castration-resistant prostate cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2468294221001763Test; https://doaj.org/toc/2468-2942Test

الوصول الحر: https://doaj.org/article/3ffddd9a193f4f66aa5b2ec72085f76aTest

المؤلفون: Milanesio M. C., Giordano S., Valabrega G.

المساهمون: Milanesio M.C., Giordano S., Valabrega G.

مصطلحات موضوعية: BRCA reversion mutation, DNA homologous recombination, DNA mismatch repair, DNA repair deficiency, Epithelial ovarian cancer, PARP inhibitors

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32455819; info:eu-repo/semantics/altIdentifier/wos/WOS:000539246000256; volume:12; issue:5; firstpage:1315; lastpage:1334; numberofpages:20; journal:CANCERS; http://hdl.handle.net/2318/1742201Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85085503210

الإتاحة: https://doi.org/10.3390/cancers12051315Test
http://hdl.handle.net/2318/1742201Test

المؤلفون: Clara Elizabeth Tandar, Taylor Ryan McFarland, Umang Swami, Neeraj Agarwal

المصدر: Cancer Treatment and Research Communications, Vol 29, Iss, Pp 100480-(2021)

مصطلحات موضوعية: Male, Cancer Research, Poly ADP ribose polymerase, Poly(ADP-ribose) Polymerase Inhibitors, medicine.disease_cause, Germline, Frameshift mutation, Olaparib, chemistry.chemical_compound, Prostate cancer, Medicine, Humans, Rucaparib, RC254-282, Castration-resistant prostate cancer, BRCA2 Protein, Mutation, Liquid biopsy, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, BRCA2, Reversion mutation, Prostatic Neoplasms, Castration-Resistant, PARP inhibitor, Oncology, chemistry, Cancer research, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a3a96b293bd0998b96aeadd1381276Test
http://www.sciencedirect.com/science/article/pii/S2468294221001763Test